NA
LLY icon

Nordwand Advisors’s Eli Lilly LLY Stock Holding History

Nordwand Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14M Sell
11,706
-88
-0.7% -$89.9K 2.15% 10
2026
Q1 		$10.8M Sell
11,794
-205
-2% -$208K 1.9% 15
2025
Q4 		$12.9M Buy
11,999
+20
+0.2% +$19.1K 2.25% 9
2025
Q3 		$9.14M Buy
11,979
+1,031
+9% +$767K 1.45% 17
2025
Q2 		$8.53M Buy
+10,948
New +$8.51M 1.34% 16

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nordwand Advisors's LLY Position: Q2 2026 in Review

Nordwand Advisors reduced its Eli Lilly (LLY) stake by 0.75% in Q2 2026, selling an estimated $89.9K and leaving 11,706 shares worth $14M. The position accounts for 2.15% of the portfolio, ranked #10.

Nordwand Advisors first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Nordwand Advisors held 11,706 shares of Eli Lilly worth $14M as of Q2 2026.
  • Nordwand Advisors sold 88 Eli Lilly shares in Q2 2026, an estimated $89.9K.
  • Eli Lilly made up 2.15% of Nordwand Advisors's portfolio in Q2 2026, its #10 holding.
  • Nordwand Advisors first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Nordwand Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.